Chiquita Brooks-LaSure last Thursday was formally sworn in as Administrator of the Centers for Medicare and Medicaid Services (CMS), setting in place another key Biden administration official with influence on the 340B program.
Although CMS does not control federal 340B program policy directly, it controls the Medicaid drug rebate program, decisions about which can have a big impact on 340B. In January 2020, for example, CMS published guidance for states on best practices for avoiding 340B duplicate discounts.
Chiquita Brooks-LaSure last Thursday was formally sworn in as Administrator of the Centers for Medicare and Medicaid Services (CMS), setting in place another key Biden administration official with influence on the 340B program.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
